Ventura County economic development plan approved
Ventura County’s Board of Supervisors has approved the first economic development plan in the history of the county. The board voted 5-0 to approve the countywide “Economic Vitality Strategic Plan” at its board meeting on Oct. 24. Officials said the plan was the product of four public sessions and was designed to “foster economic growth Read More →
Read More →Amgen studying genes to target pain conditions
For the next year, Amgen and Boston Children’s Hospital will use genetic analysis to study pain sensitivity. The biotech giant based in Thousand Oaks will work with patients who have abnormal pain conditions, and the hospital will validate genetic markers as potential targets for new therapies, the two announced in a press release on Oct. 16. “Traditional Read More →
Read More →
Amgen settles with AbbVie over Humira biosimilar litigation
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Museum of Ventura County replaces board with 11 new members
Updated at 10:20 a.m. Sept. 29: The Museum of Ventura County has replaced its board of directors and elected 11 new board members, it announced in a news release Sept. 28. The museum has faced financial woes and possible closure in the past few years. It streamlined its budget to $1.1 million as of May Read More →
Read More →Amgen settles with AbbVie over Humira biosimilar
Thousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →
Read More →Amgen agrees to develop biosimilars for Chinese market
Increasing its global footprint in the biosimilars market, Amgen announced Sept. 26 that it had formed an exclusive co-development agreement with Chinese drug manufacturer Simcere Pharmaceutical Group. The agreement aims to bring four oncology and inflammation biosimilars in Amgen’s portfolio to commercialization in China. The Thousand Oaks-based biotechnology company will produce and submit approval applications Read More →
Read More →Dole Food lays off another 400 berry workers
Westlake Village-based Dole Food continued to downsize its California berry operations with a layoff of more than 400 workers in Watsonville. The company submitted a notice to the California Employment Development Department at the end of August stating that the employees would be laid off effective Oct. 28. This comes after the announcement that 172 Read More →
Read More →
